Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus

PLoS ONE - United States
doi 10.1371/journal.pone.0103981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Exenatide (Byetta) as a Novel Treatment Option for Type 2 Diabetes Mellitus

Baylor University Medical Center Proceedings
Medicine
2006English

Honey as a Sole Treatment of Type 2 Diabetes Mellitus

Endocrinology & Metabolic Syndrome
2016English

Novel Approaches to the Treatment of Hyperglycaemia in Type 2 Diabetes Mellitus

Internal Medicine Journal
Internal Medicine
2016English

Tissue Factor Levels in Type 2 Diabetes Mellitus

Inflammation Research
ImmunologyPharmacology
2017English

"Type 1 on Type 2" Diabetes Mellitus: Autoimmune Type 1 Diabetes Superimposed on Established Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2007English

Insulinization: A Promising Strategy for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Circulating microRNAs as Biomarkers for Type 1 Diabetes Mellitus

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus

Enzyme Engineering
2015English

Type 1 Diabetes Mellitus

Pediatrics in Review
MedicineChild HealthPediatricsPerinatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy